Life Science - A Vibrant Investment


According to the Venture One Report on Q2 2002 Investments, "The amount invested in healthcare companies rose 42%, to $1.7 billion, while deal flow grew 32% from last quarter. Furthermore, healthcare companies now receive over one-third of all venture capital investment, whereas during the Internet boom their allocation was in the single digits."
People Invest in Healthcare
In the world's richest countries, healthcare is a major public issue. The public expects and seeks:

  
 
    

    
Ever- increasing quality of 
      care 
  
  
 
    

    
Medical innovations
  
  
 
    

    
Pain-free treatments
  
  
 
    

    
Minimal invasions
  

Governments, Insurance companies and health funds seek:



  
 
    

    
Innovations that can help reduce costs while improving patient care or recovery 
  
  
 
    

    
Out-patient or home care options where possible
  
  
 
    

    
Cost-effective solutions for the delivery of optimum care. 
  

  
Vitalife Life Sciences Fund has successfully targeted this market, selecting medical innovations that meet these parameters. 


  New Therapeutic Medical Devices 

  One of the keys to profit is to design a device that uses some form of disposable unit - and this becomes the money-maker over time. Taking advantage of new technologies and computer sciences, more and more medical devices can be miniaturized and invasive procedures can be minimized. Products can be sold to a bigger, broader market of clinics, field clinics and private practices, rather than large single units to hospitals.  
"Vitalife is well placed to identify, invest in and lead life science and medical device innovations. Israel is a global leader in this field, and we are ideally positioned to find and support the most talented enterpreneurs."Avi Ludomirski